Cofounders

  • Eric Witze, PhD

    Eric has worked to establish the regulation of cancer signaling pathways by palmitoylation and demonstrate the potential as a therapeutic target in cancer.

  • George Burslem, PhD

    George works at the chemistry/biology interface with expertise extending from chemical biology, to medicinal chemistry and drug discovery.

  • Donita Brady, PhD

    Donita utilizes biochemistry, cell biology, and in vivo mouse models to dissect the molecular regulation of signal transduction pathways in cancer.